IRDAI's commission regulations are due by September 2026, with law requiring the Authority to frame regulations within six months of an Insurance Act mandate, former IRDAI Member (Distribution) Nilesh Sathe told ETBFSI on February 11 2026, cautioning that speculation on caps or TER-like expense limits is premature until a draft discussion paper goes through Insurance Advisory Council and board approval. Sathe said regulating every payout to every agent, bank or broker is neither feasible nor the regulator's role, but prescribing overall commission ceilings by product category - term, savings, annuity - and widening the definition of what counts as payout is likely, a nuance that will shape how the 30% agency commission compares with Bima Sugam's proposed 5-7% settlement fee.
Context: Why September Became Non-Negotiable
Sathe's point is procedural: "Wherever the Act mandates regulations, IRDAI has to frame them within six months," with extensions rare and typically requiring government intervention. The trigger is the SBSR (Amendment of Insurance Laws) Act 2025 and the July 30 Corporate Agent amendment which already amended the fee definition to include "commission and other receipts" such as branding, marketing, display and shared-service fees - an early broadening of the payout definition Sathe anticipated. The backdrop is EY's FY25 data cited by ETBFSI that commissions grew much faster than premiums - double-digit in life and health - prompting the debate on sustainability that led IRDAI in May to withhold variable pay of CEOs at EoM-breaching insurers and in August to bar four insurers from opening branches under Regulation 22(1)(b)(c). Bima Sugam's September-end motor/health/term go-live (Business Standard June 30, Ditto July 11) with its non-commission marketplace model adds competitive pressure: a 5-7% settlement fee versus ~30% agency commission cannot coexist without rewriting incentives.
Implication: Ceilings vs Micromanagement - What Changes for Distributors and Buyers
A ceiling-by-product approach would cap, for example, term at a higher percentage than annuity, letting insurers allocate inside the cap as a commercial decision - exactly Sathe's "within the ceiling, how much an insurer pays to whom remains commercial." For bancassurance-heavy private life insurers and standalone health insurers driving retail health +47% (Niva Bupa Q1) and private GWP +17% in January (Kotak), the implication is not a ban on high payouts but a reclassification: payments now labelled as branding or business support will count toward the cap and toward EoM, and foreign-majority corporate agents earning Rs 10 crore-plus must disclose commissions and related-party transactions on their website. For policyholders, ceilings should reduce mis-selling incentives that BimaNiti linked to Rs 26,000 crore of rejections (up 19% YoY, 36% for "not covered") and to persistency pain (Rs 2.80 lakh crore surrenders FY25, 39% of benefits), but only if the ceiling is paired with the tagging and NOC mobility rules that let good sellers move and bad ones face board scrutiny.
Action or Watch-Item: What to Watch Before September 30
Track three milestones: first, IRDAI's draft or discussion paper - Sathe notes this must precede any rule and will invite public comments; second, the Insurance Advisory Council placement; third, board approval and gazette notification. No draft has been published as of September 3 per live searches, so any insurer or distributor quoting "new commission caps" before the draft is pre-judging. If you are buying term or savings between now and September, ask the distributor to disclose total compensation (commission plus rewards, not just base commission) and compare the same product on Bima Sugam once motor/health/term are live at month-end - the platform's minimal transparent fee is the benchmark the ceiling will be judged against. For shareholders, watch Q2 disclosures: insurers breaching EoM in FY25 already took board warnings; a commission ceiling inside EoM doubles the constraint.